PRMT5 and rheumatoid arthritis: As shown in Figure 5A, a specific inhibitor of PRMT5 decreased phosphorylated IKK (pIKK), as well as phosphorylation and degradation of IκBα in TNF‐α‐stimulated RA FLSs.